Pharma Globenewswire

Crohn’s Disease Market Set for Significant Growth: Rising Prevalence, Biologic Innovations, and Emerging Therapies Drive Expansion Through 2034

22 May 2026

The Crohn’s Disease market is experiencing robust expansion across the 7 Major Markets (7MM). The market size is expected to grow from USD 11,367 million in 2025 to USD 16,840 million in 2034, reflecting a CAGR of 4.40%. This steady growth is

Market Insights·News·Reports

Infusion Pumps Market Projected to Grow at a Robust CAGR of ~10% by 2032

21 May 2026

Infusion Pumps Companies are B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corporation, Medtronic plc., Fresenius Kabi, CareFusion Corporation, Smiths Medical, Koninklijke Philips NV, Micrel Medical Devices SA, Terumo Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., F. Hoffmann-La Roche Ltd., Johnson

Clinical Trials·News·Reports

Alcohol Use Disorder Pipeline Set for Transformational Progress by 2026 with 25+ Therapies

21 May 2026

Alcohol Use Disorder (AUD) companies such as Adial Pharmaceuticals, Imbrium Therapeutics, BioCorRx Pharmaceuticals, Beckley Psytech, Cybin, BioXcel Therapeutics, MediciNova, and others are actively redefining the future of addiction therapeutics through innovative drug development strategies, precision medicine approaches, and expanding clinical pipelines. DelveInsight’s,

Clinical Trials·News·Reports

Atopic Dermatitis Pipeline Set for Transformational Expansion by 2026 with 120+ Therapies

21 May 2026

Atopic Dermatitis companies such as Innocare Pharma, Apogee Therapeutics, Celldex Therapeutics, Aclaris Therapeutics, BioCryst Pharmaceuticals, Vanda Pharmaceuticals, and several others are actively reshaping the future of Atopic Dermatitis (AD) therapeutics through innovative drug development strategies, targeted immunological approaches, and a rapidly expanding

Uncategorised

Big Data in Healthcare Market Expected to Witness Robust Growth by 2032 Across Global Markets | DelveInsight

21 May 2026

The Big Data in Healthcare market is anticipated to grow at a substantial CAGR during the forecast period from 2025 to 2032 across key global regions, including North America, Europe, Asia-Pacific, and Rest of the World. The market growth is expected to

Uncategorised

Exosomes Pipeline Insights 2026: Emerging Therapies, Clinical Advances, and Industry Leaders

21 May 2026

DelveInsight’s “Exosomes Pipeline Insights 2026” Report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in Exosomes pipeline landscape. It covers the Exosomes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Exosomes pipeline therapeutics assessment by

Uncategorised

Pulmonary Arterial Hypertension Market Set for Robust Growth Driven by Innovative Therapies, Expanding Pipeline, and Rising Global Disease Burden Through 2036

21 May 2026

According to DelveInsight’s analysis, the Pulmonary Arterial Hypertension market size was ~USD 8 billion in the leading markets (the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan) in 2025. The market is poised for continued expansion

Uncategorised

Growth Hormone Deficiency Market Expansion Driven by Rising Cases, Advancing Therapies, and Increasing Treatment Adoption Across Seven Major Markets Forecast 2025 to 2034 with Market Size Rising from USD 1,626 Million to USD 3,304 Million

20 May 2026

The Growth Hormone Deficiency market is experiencing consistent expansion supported by increasing disease awareness, improved diagnostic capabilities, and the rising availability of long-acting therapeutic options. The Growth Hormone Deficiency market size in the seven major markets is expected to grow from USD

Uncategorised

Inclusion Body Myositis Therapeutics Market Size in the 7MM is anticipated to increase at a significant CAGR by 2034, estimates DelveInsight

20 May 2026

DelveInsight’s “Inclusion Body Myositis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Inclusion Body Myositis, historical and forecasted epidemiology as well as the Inclusion Body Myositis market trends in the United States, EU4 (Germany, France, Italy, and

Latest

Crohn’s Disease Market Set for Significant Growth: Rising Prevalence, Biologic Innovations, and Emerging Therapies Drive Expansion Through 2034

Infusion Pumps Market Projected to Grow at a Robust CAGR of ~10% by 2032

Alcohol Use Disorder Pipeline Set for Transformational Progress by 2026 with 25+ Therapies

Atopic Dermatitis Pipeline Set for Transformational Expansion by 2026 with 120+ Therapies

Big Data in Healthcare Market Expected to Witness Robust Growth by 2032 Across Global Markets | DelveInsight

Exosomes Pipeline Insights 2026: Emerging Therapies, Clinical Advances, and Industry Leaders

Pulmonary Arterial Hypertension Market Set for Robust Growth Driven by Innovative Therapies, Expanding Pipeline, and Rising Global Disease Burden Through 2036

Growth Hormone Deficiency Market Expansion Driven by Rising Cases, Advancing Therapies, and Increasing Treatment Adoption Across Seven Major Markets Forecast 2025 to 2034 with Market Size Rising from USD 1,626 Million to USD 3,304 Million

Inclusion Body Myositis Therapeutics Market Size in the 7MM is anticipated to increase at a significant CAGR by 2034, estimates DelveInsight

Recent Posts

Banner

Newsletter

Authors